+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Molybdenum-99 Market - Global Forecast 2026-2032

  • Report

  • 192 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6145820
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Molybdenum-99 Market is projected to reach USD 979.14 Million in 2026. It is expected to continue growing at a CAGR of 5.75%, reaching USD 1.37 Billion by 2032.

Molybdenum-99: Executive Overview

Molybdenum-99 (Mo-99) is a radioactive isotope used primarily to produce technetium-99m, a critical diagnostic radionuclide for nuclear medicine imaging. Its importance is shaped by short half-life, specialized production, stringent transport requirements, reactor and processing-plant availability, and the need for reliable generator distribution. The market is therefore influenced by medical demand, nuclear infrastructure, regulatory oversight, security controls, and international supply-chain coordination.

Supply Resilience Is Reshaping the Mo-99 Landscape

The Mo-99 landscape is shifting toward greater supply resilience. Aging research reactors, planned maintenance, unplanned outages, constrained processing capacity, and dependence on specialized logistics have highlighted the vulnerability of concentrated production networks. Industry and public-sector responses include reactor modernization, alternative production routes, improved target technology, domestic or regional capacity development, and stronger coordination among producers, processors, distributors, hospitals, and regulators. Reduced reliance on highly enriched uranium in target production is also an important technical and policy direction.

AI Improves Planning, Quality Control, and Nuclear-Medicine Operations

Artificial intelligence can support the Mo-99 value chain without replacing the need for licensed facilities and expert oversight. Applications include demand forecasting for technetium-99m generators, production scheduling, predictive maintenance, anomaly detection, transport planning, image-assisted quality assurance, and optimization of clinical workflows. The cumulative impact will depend on validated data, interoperable systems, cybersecurity, explainability, and compliance with nuclear, pharmaceutical, and medical-device requirements. AI is most valuable when integrated with operational controls rather than treated as a standalone solution.

Regional Priorities Differ Across the Global Mo-99 Ecosystem

North America emphasizes supply assurance, reactor and processing resilience, domestic capability, and regulatory coordination. Europe focuses on cross-border continuity, aging infrastructure, low-enriched-uranium target conversion, and coordinated healthcare access. Asia-Pacific combines expanding nuclear-medicine use with significant production, processing, and technology capabilities, while also addressing logistics and uneven access. Latin America is focused on dependable imports, regional distribution, and expansion of nuclear-medicine services. The Middle East is developing diagnostic capacity and specialized healthcare infrastructure, with supply continuity often linked to international partnerships. Africa faces uneven access to reactors, processing, transport, and nuclear-medicine facilities, making regional cooperation and technical capacity especially important.

Economic and Security Groups Shape Coordination and Access

ASEAN countries are linked by growing healthcare needs, varied regulatory maturity, and the importance of dependable cross-border logistics. BRICS members include major producers, users, and emerging nuclear-medicine systems, creating opportunities for technical cooperation alongside differing national priorities. The European Union benefits from regulatory and infrastructure coordination but must manage cross-border dependencies and facility outages. G7 economies place strong emphasis on supply security, nonproliferation, advanced technology, and resilient medical access. GCC states are investing in specialized healthcare and may use centralized procurement and international partnerships to improve availability. NATO members have a broader resilience agenda that includes critical infrastructure, transport security, emergency preparedness, and continuity of essential medical services.

Country Capabilities Reflect Distinct Production and Clinical Roles

Australia contributes nuclear and radiopharmaceutical capabilities and supports regional access. Brazil is expanding nuclear-medicine capacity while managing infrastructure and distribution challenges. Canada has an important role in isotope production and research-reactor capability. China combines substantial nuclear, industrial, and healthcare resources with growing domestic demand. France, Germany, Italy, Spain, and the United Kingdom contribute through advanced healthcare systems, regulatory expertise, research infrastructure, and cross-border European supply links. India is developing both production capabilities and clinical access across a large and diverse healthcare system. Japan and South Korea maintain sophisticated nuclear and medical-technology ecosystems. Mexico is strengthening nuclear-medicine services and depends on robust regional supply arrangements. Russia has nuclear and isotope expertise, though international logistics and geopolitical conditions affect external participation. The United States remains a major clinical market with extensive regulatory, research, production, and distribution requirements.

Prioritize Redundancy, Transparency, and Validated Digital Operations

Industry leaders should diversify production and processing routes, support reactor and facility maintenance, and establish tested contingency plans for outages and transport disruptions. Long-term contracts and transparent scheduling can improve coordination between isotope suppliers, generator manufacturers, distributors, and healthcare providers. Organizations should continue conversion toward low-enriched-uranium target practices where technically and economically appropriate, while maintaining strict safeguards and quality controls. AI investments should begin with auditable use cases such as maintenance, inventory visibility, and demand planning. Leaders should also strengthen regulatory engagement, cybersecurity, workforce training, emergency logistics, and equitable access programs across underserved regions.

Methodology: Structured Review of the Mo-99 Supply and Use Ecosystem

This executive summary uses a qualitative synthesis of the Mo-99 ecosystem, examining isotope production, target technology, processing, generator supply, transport, regulation, nuclear-medicine demand, infrastructure resilience, and digital transformation. The assessment compares the required regions, economic and security groups, and countries through their documented roles in production, healthcare delivery, policy, research, logistics, and international cooperation. It deliberately excludes market estimates, market sizing, market shares, forecasts, and company-specific claims. Findings are framed as evidence-based structural insights rather than numerical market projections.

Resilience and Collaboration Will Define Mo-99’s Next Phase

Mo-99 remains strategically important because reliable access to technetium-99m supports routine diagnostic imaging across many healthcare systems. The central challenge is not only production volume but dependable coordination across reactors, processors, transport networks, regulators, and clinical providers. Regional diversification, low-enriched-uranium adoption, infrastructure renewal, responsible AI, and stronger international cooperation can reduce vulnerability. Organizations that combine technical reliability with transparent planning and regulatory discipline will be best positioned to support continuity of nuclear-medicine services.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Molybdenum-99 Market, by Production Method
7.1. Introduction
7.2. Accelerator Based Production
7.3. Neutron Capture
7.4. Fission-based Production
7.4.1. High Enriched Uranium
7.4.2. Low Enriched Uranium
8. Molybdenum-99 Market, by Application
8.1. Introduction
8.2. Diagnostic Imaging
8.2.1. Cardiology
8.2.2. Neurology
8.2.3. Oncology
8.3. Research & Development
9. Molybdenum-99 Market, by End-User
9.1. Introduction
9.2. Hospitals
9.3. Diagnostic Centres
9.4. Research Institutions
10. Molybdenum-99 Market, by Region
10.1. Introduction
10.2. Asia-Pacific
10.3. Europe
10.4. North America
10.5. Latin America
10.6. Africa
10.7. Middle East
11. Molybdenum-99 Market, by Group
11.1. Introduction
11.2. NATO
11.3. G7
11.4. BRICS
11.5. European Union
11.6. ASEAN
11.7. GCC
12. Molybdenum-99 Market, by Country
12.1. Introduction
12.2. United States
12.3. China
12.4. Germany
12.5. Japan
12.6. India
12.7. United Kingdom
12.8. France
12.9. Canada
12.10. Australia
12.11. Italy
12.12. Brazil
12.13. South Korea
12.14. Mexico
12.15. Russia
12.16. Spain
13. Competitive Landscape
13.1. Market Share Analysis, 2025
13.2. Market Concentration Analysis, 2025
13.2.1. Concentration Ratio (CR)
13.2.2. Herfindahl Hirschman Index (HHI)
13.3. Recent Developments & Impact Analysis, 2025
13.4. Product Portfolio Analysis, 2025
13.5. Benchmarking Analysis, 2025
14. Company Profiles
14.1. Australian Nuclear Science and Technology Organisation
14.2. Cardinal Health, Inc
14.3. China National Nuclear Corporation
14.4. Climax Molybdenum Company by Freeport-McMoRan Inc.
14.5. Curium Pharma
14.6. Eckert & Ziegler Radiopharma GmbH
14.7. Flibe Energy, Inc.
14.8. General Atomics
14.9. IBA Radiopharma Solutions
14.10. IRE
14.11. Isotope JSC
14.12. Lantheus Holdings, Inc.
14.13. Nordion Inc
14.14. NorthStar Medical Radioisotopes, LLC
14.15. Northwest Medical Isotopes, LLC
14.16. NRG PALLAS
14.17. NTP Radioisotopes SOC Ltd
14.18. Plansee SE
14.19. SHINE Technologies, LLC
14.20. Springer Nature Limited
15. Key Experts
LIST OF FIGURES
FIGURE 1. Global Molybdenum-99 Market, Years Considered for the Study
FIGURE 2. Global Molybdenum-99 Market, Research Design
FIGURE 3. Global Molybdenum-99 Market, Research Framework
FIGURE 4. Global Molybdenum-99 Market, Data Triangulation
FIGURE 5. Global Molybdenum-99 Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Molybdenum-99 Market Size, by Production Method, 2025 vs 2032 (%)
FIGURE 7. Global Molybdenum-99 Market Size, by Production Method, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Molybdenum-99 Market Size, by Application, 2025 vs 2032 (%)
FIGURE 9. Global Molybdenum-99 Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Molybdenum-99 Market Size, by End-User, 2025 vs 2032 (%)
FIGURE 11. Global Molybdenum-99 Market Size, by End-User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Molybdenum-99 Market Size, by Region, 2025 vs 2032 (%)
FIGURE 13. Global Molybdenum-99 Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Molybdenum-99 Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 15. Global Molybdenum-99 Market Size, by Country, 2025 vs 2032 (%)
FIGURE 16. Global Molybdenum-99 Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Molybdenum-99 Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Molybdenum-99 Market Segmentation & Coverage
TABLE 2. Global Molybdenum-99 Market Size, 2017-2032 (USD Million)
TABLE 3. Global Molybdenum-99 Market Size, by Production Method, 2017-2032 (USD Million)
TABLE 4. Global Accelerator Based Production Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Accelerator Based Production Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Accelerator Based Production Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Neutron Capture Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Neutron Capture Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Neutron Capture Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Fission-based Production Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Fission-based Production Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Fission-based Production Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global High Enriched Uranium Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global High Enriched Uranium Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global High Enriched Uranium Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Low Enriched Uranium Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Low Enriched Uranium Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Low Enriched Uranium Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Molybdenum-99 Market Size, by Application, 2017-2032 (USD Million)
TABLE 20. Global Diagnostic Imaging Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Diagnostic Imaging Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Diagnostic Imaging Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Cardiology Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Cardiology Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Cardiology Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Neurology Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Neurology Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Neurology Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Research & Development Market Size, by Region, 2017-2032 (USD Million)
TABLE 33. Global Research & Development Market Size, by Group, 2017-2032 (USD Million)
TABLE 34. Global Research & Development Market Size, by Country, 2017-2032 (USD Million)
TABLE 35. Global Molybdenum-99 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 36. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Diagnostic Centres Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Diagnostic Centres Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Diagnostic Centres Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Research Institutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Research Institutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Research Institutions Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Molybdenum-99 Market Size, by Region, 2017-2032 (USD Million)
TABLE 46. Asia-Pacific Molybdenum-99 Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Asia-Pacific Molybdenum-99 Market Size, by Production Method, 2017-2032 (USD Million)
TABLE 48. Asia-Pacific Molybdenum-99 Market Size, by Fission-based Production, 2017-2032 (USD Million)
TABLE 49. Asia-Pacific Molybdenum-99 Market Size, by Application, 2017-2032 (USD Million)
TABLE 50. Asia-Pacific Molybdenum-99 Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 51. Asia-Pacific Molybdenum-99 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 52. Europe Molybdenum-99 Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Europe Molybdenum-99 Market Size, by Production Method, 2017-2032 (USD Million)
TABLE 54. Europe Molybdenum-99 Market Size, by Fission-based Production, 2017-2032 (USD Million)
TABLE 55. Europe Molybdenum-99 Market Size, by Application, 2017-2032 (USD Million)
TABLE 56. Europe Molybdenum-99 Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 57. Europe Molybdenum-99 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 58. North America Molybdenum-99 Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. North America Molybdenum-99 Market Size, by Production Method, 2017-2032 (USD Million)
TABLE 60. North America Molybdenum-99 Market Size, by Fission-based Production, 2017-2032 (USD Million)
TABLE 61. North America Molybdenum-99 Market Size, by Application, 2017-2032 (USD Million)
TABLE 62. North America Molybdenum-99 Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 63. North America Molybdenum-99 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 64. Latin America Molybdenum-99 Market Size, by Region, 2017-2032 (USD Million)
TABLE 65. Latin America Molybdenum-99 Market Size, by Production Method, 2017-2032 (USD Million)
TABLE 66. Latin America Molybdenum-99 Market Size, by Fission-based Production, 2017-2032 (USD Million)
TABLE 67. Latin America Molybdenum-99 Market Size, by Application, 2017-2032 (USD Million)
TABLE 68. Latin America Molybdenum-99 Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 69. Latin America Molybdenum-99 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 70. Africa Molybdenum-99 Market Size, by Region, 2017-2032 (USD Million)
TABLE 71. Africa Molybdenum-99 Market Size, by Production Method, 2017-2032 (USD Million)
TABLE 72. Africa Molybdenum-99 Market Size, by Fission-based Production, 2017-2032 (USD Million)
TABLE 73. Africa Molybdenum-99 Market Size, by Application, 2017-2032 (USD Million)
TABLE 74. Africa Molybdenum-99 Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 75. Africa Molybdenum-99 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 76. Middle East Molybdenum-99 Market Size, by Region, 2017-2032 (USD Million)
TABLE 77. Middle East Molybdenum-99 Market Size, by Production Method, 2017-2032 (USD Million)
TABLE 78. Middle East Molybdenum-99 Market Size, by Fission-based Production, 2017-2032 (USD Million)
TABLE 79. Middle East Molybdenum-99 Market Size, by Application, 2017-2032 (USD Million)
TABLE 80. Middle East Molybdenum-99 Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 81. Middle East Molybdenum-99 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 82. Global Molybdenum-99 Market Size, by Group, 2017-2032 (USD Million)
TABLE 83. NATO Molybdenum-99 Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. NATO Molybdenum-99 Market Size, by Production Method, 2017-2032 (USD Million)
TABLE 85. NATO Molybdenum-99 Market Size, by Fission-based Production, 2017-2032 (USD Million)
TABLE 86. NATO Molybdenum-99 Market Size, by Application, 2017-2032 (USD Million)
TABLE 87. NATO Molybdenum-99 Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 88. NATO Molybdenum-99 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 89. G7 Molybdenum-99 Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. G7 Molybdenum-99 Market Size, by Production Method, 2017-2032 (USD Million)
TABLE 91. G7 Molybdenum-99 Market Size, by Fission-based Production, 2017-2032 (USD Million)
TABLE 92. G7 Molybdenum-99 Market Size, by Application, 2017-2032 (USD Million)
TABLE 93. G7 Molybdenum-99 Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 94. G7 Molybdenum-99 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 95. BRICS Molybdenum-99 Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. BRICS Molybdenum-99 Market Size, by Production Method, 2017-2032 (USD Million)
TABLE 97. BRICS Molybdenum-99 Market Size, by Fission-based Production, 2017-2032 (USD Million)
TABLE 98. BRICS Molybdenum-99 Market Size, by Application, 2017-2032 (USD Million)
TABLE 99. BRICS Molybdenum-99 Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 100. BRICS Molybdenum-99 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 101. European Union Molybdenum-99 Market Size, by Group, 2017-2032 (USD Million)
TABLE 102. European Union Molybdenum-99 Market Size, by Production Method, 2017-2032 (USD Million)
TABLE 103. European Union Molybdenum-99 Market Size, by Fission-based Production, 2017-2032 (USD Million)
TABLE 104. European Union Molybdenum-99 Market Size, by Application, 2017-2032 (USD Million)
TABLE 105. European Union Molybdenum-99 Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 106. European Union Molybdenum-99 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 107. ASEAN Molybdenum-99 Market Size, by Group, 2017-2032 (USD Million)
TABLE 108. ASEAN Molybdenum-99 Market Size, by Production Method, 2017-2032 (USD Million)
TABLE 109. ASEAN Molybdenum-99 Market Size, by Fission-based Production, 2017-2032 (USD Million)
TABLE 110. ASEAN Molybdenum-99 Market Size, by Application, 2017-2032 (USD Million)
TABLE 111. ASEAN Molybdenum-99 Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 112. ASEAN Molybdenum-99 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 113. GCC Molybdenum-99 Market Size, by Group, 2017-2032 (USD Million)
TABLE 114. GCC Molybdenum-99 Market Size, by Production Method, 2017-2032 (USD Million)
TABLE 115. GCC Molybdenum-99 Market Size, by Fission-based Production, 2017-2032 (USD Million)
TABLE 116. GCC Molybdenum-99 Market Size, by Application, 2017-2032 (USD Million)
TABLE 117. GCC Molybdenum-99 Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 118. GCC Molybdenum-99 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 119. Global Molybdenum-99 Market Size, by Country, 2017-2032 (USD Million)
TABLE 120. United States Molybdenum-99 Market Size, 2017-2032 (USD Million)
TABLE 121. United States Molybdenum-99 Market Size, by Production Method, 2017-2032 (USD Million)
TABLE 122. United States Molybdenum-99 Market Size, by Fission-based Production, 2017-2032 (USD Million)
TABLE 123. United States Molybdenum-99 Market Size, by Application, 2017-2032 (USD Million)
TABLE 124. United States Molybdenum-99 Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 125. United States Molybdenum-99 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 126. China Molybdenum-99 Market Size, 2017-2032 (USD Million)
TABLE 127. China Molybdenum-99 Market Size, by Production Method, 2017-2032 (USD Million)
TABLE 128. China Molybdenum-99 Market Size, by Fission-based Production, 2017-2032 (USD Million)
TABLE 129. China Molybdenum-99 Market Size, by Application, 2017-2032 (USD Million)
TABLE 130. China Molybdenum-99 Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 131. China Molybdenum-99 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 132. Germany Molybdenum-99 Market Size, 2017-2032 (USD Million)
TABLE 133. Germany Molybdenum-99 Market Size, by Production Method, 2017-2032 (USD Million)
TABLE 134. Germany Molybdenum-99 Market Size, by Fission-based Production, 2017-2032 (USD Million)
TABLE 135. Germany Molybdenum-99 Market Size, by Application, 2017-2032 (USD Million)
TABLE 136. Germany Molybdenum-99 Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 137. Germany Molybdenum-99 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 138. Japan Molybdenum-99 Market Size, 2017-2032 (USD Million)
TABLE 139. Japan Molybdenum-99 Market Size, by Production Method, 2017-2032 (USD Million)
TABLE 140. Japan Molybdenum-99 Market Size, by Fission-based Production, 2017-2032 (USD Million)
TABLE 141. Japan Molybdenum-99 Market Size, by Application, 2017-2032 (USD Million)
TABLE 142. Japan Molybdenum-99 Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 143. Japan Molybdenum-99 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 144. India Molybdenum-99 Market Size, 2017-2032 (USD Million)
TABLE 145. India Molybdenum-99 Market Size, by Production Method, 2017-2032 (USD Million)
TABLE 146. India Molybdenum-99 Market Size, by Fission-based Production, 2017-2032 (USD Million)
TABLE 147. India Molybdenum-99 Market Size, by Application, 2017-2032 (USD Million)
TABLE 148. India Molybdenum-99 Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 149. India Molybdenum-99 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 150. United Kingdom Molybdenum-99 Market Size, 2017-2032 (USD Million)
TABLE 151. United Kingdom Molybdenum-99 Market Size, by Production Method, 2017-2032 (USD Million)
TABLE 152. United Kingdom Molybdenum-99 Market Size, by Fission-based Production, 2017-2032 (USD Million)
TABLE 153. United Kingdom Molybdenum-99 Market Size, by Application, 2017-2032 (USD Million)
TABLE 154. United Kingdom Molybdenum-99 Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 155. United Kingdom Molybdenum-99 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 156. France Molybdenum-99 Market Size, 2017-2032 (USD Million)
TABLE 157. France Molybdenum-99 Market Size, by Production Method, 2017-2032 (USD Million)
TABLE 158. France Molybdenum-99 Market Size, by Fission-based Production, 2017-2032 (USD Million)
TABLE 159. France Molybdenum-99 Market Size, by Application, 2017-2032 (USD Million)
TABLE 160. France Molybdenum-99 Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 161. France Molybdenum-99 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 162. Canada Molybdenum-99 Market Size, 2017-2032 (USD Million)
TABLE 163. Canada Molybdenum-99 Market Size, by Production Method, 2017-2032 (USD Million)
TABLE 164. Canada Molybdenum-99 Market Size, by Fission-based Production, 2017-2032 (USD Million)
TABLE 165. Canada Molybdenum-99 Market Size, by Application, 2017-2032 (USD Million)
TABLE 166. Canada Molybdenum-99 Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 167. Canada Molybdenum-99 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 168. Australia Molybdenum-99 Market Size, 2017-2032 (USD Million)
TABLE 169. Australia Molybdenum-99 Market Size, by Production Method, 2017-2032 (USD Million)
TABLE 170. Australia Molybdenum-99 Market Size, by Fission-based Production, 2017-2032 (USD Million)
TABLE 171. Australia Molybdenum-99 Market Size, by Application, 2017-2032 (USD Million)
TABLE 172. Australia Molybdenum-99 Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 173. Australia Molybdenum-99 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 174. Italy Molybdenum-99 Market Size, 2017-2032 (USD Million)
TABLE 175. Italy Molybdenum-99 Market Size, by Production Method, 2017-2032 (USD Million)
TABLE 176. Italy Molybdenum-99 Market Size, by Fission-based Production, 2017-2032 (USD Million)
TABLE 177. Italy Molybdenum-99 Market Size, by Application, 2017-2032 (USD Million)
TABLE 178. Italy Molybdenum-99 Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 179. Italy Molybdenum-99 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 180. Brazil Molybdenum-99 Market Size, 2017-2032 (USD Million)
TABLE 181. Brazil Molybdenum-99 Market Size, by Production Method, 2017-2032 (USD Million)
TABLE 182. Brazil Molybdenum-99 Market Size, by Fission-based Production, 2017-2032 (USD Million)
TABLE 183. Brazil Molybdenum-99 Market Size, by Application, 2017-2032 (USD Million)
TABLE 184. Brazil Molybdenum-99 Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 185. Brazil Molybdenum-99 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 186. South Korea Molybdenum-99 Market Size, 2017-2032 (USD Million)
TABLE 187. South Korea Molybdenum-99 Market Size, by Production Method, 2017-2032 (USD Million)
TABLE 188. South Korea Molybdenum-99 Market Size, by Fission-based Production, 2017-2032 (USD Million)
TABLE 189. South Korea Molybdenum-99 Market Size, by Application, 2017-2032 (USD Million)
TABLE 190. South Korea Molybdenum-99 Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 191. South Korea Molybdenum-99 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 192. Mexico Molybdenum-99 Market Size, 2017-2032 (USD Million)
TABLE 193. Mexico Molybdenum-99 Market Size, by Production Method, 2017-2032 (USD Million)
TABLE 194. Mexico Molybdenum-99 Market Size, by Fission-based Production, 2017-2032 (USD Million)
TABLE 195. Mexico Molybdenum-99 Market Size, by Application, 2017-2032 (USD Million)
TABLE 196. Mexico Molybdenum-99 Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 197. Mexico Molybdenum-99 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 198. Russia Molybdenum-99 Market Size, 2017-2032 (USD Million)
TABLE 199. Russia Molybdenum-99 Market Size, by Production Method, 2017-2032 (USD Million)
TABLE 200. Russia Molybdenum-99 Market Size, by Fission-based Production, 2017-2032 (USD Million)
TABLE 201. Russia Molybdenum-99 Market Size, by Application, 2017-2032 (USD Million)
TABLE 202. Russia Molybdenum-99 Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 203. Russia Molybdenum-99 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 204. Spain Molybdenum-99 Market Size, 2017-2032 (USD Million)
TABLE 205. Spain Molybdenum-99 Market Size, by Production Method, 2017-2032 (USD Million)
TABLE 206. Spain Molybdenum-99 Market Size, by Fission-based Production, 2017-2032 (USD Million)
TABLE 207. Spain Molybdenum-99 Market Size, by Application, 2017-2032 (USD Million)
TABLE 208. Spain Molybdenum-99 Market Size, by Diagnostic Imaging, 2017-2032 (USD Million)
TABLE 209. Spain Molybdenum-99 Market Size, by End-User, 2017-2032 (USD Million)
TABLE 210. Global Molybdenum-99 Market Share, by Key Player, 2025
TABLE 211. Global Molybdenum-99 Market, Key Experts

Companies Mentioned

  • Australian Nuclear Science and Technology Organisation
  • Cardinal Health, Inc
  • China National Nuclear Corporation
  • Climax Molybdenum Company by Freeport-McMoRan Inc.
  • Curium Pharma
  • Eckert & Ziegler Radiopharma GmbH
  • Flibe Energy, Inc.
  • General Atomics
  • IBA Radiopharma Solutions
  • IRE
  • Isotope JSC
  • Lantheus Holdings, Inc.
  • Nordion Inc
  • NorthStar Medical Radioisotopes, LLC
  • Northwest Medical Isotopes, LLC
  • NRG PALLAS
  • NTP Radioisotopes SOC Ltd
  • Plansee SE
  • SHINE Technologies, LLC
  • Springer Nature Limited